4D Molecular Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $28.25 | $1.59 B | -7.1 | 61 | $0 |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $4.24 | $291.95 M | -3.13 | 54 | $0 |
 BMEA
|
Biomea Fusion, Inc. | $9.91 | $148.81 M | -1.17 | 112 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $5.90 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $17.19 | $1.29 B | -7.16 | 85 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GOSS
|
Gossamer Bio, Inc. | $0.96 | $124.06 M | -0.65 | 135 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.61 | $244.54 M | -1.32 | 152 | $2.24 M |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 LYRA
|
Lyra Therapeutics, Inc. | $0.26 | $19.53 M | -0.27 | 88 | $1.56 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.91 | $652.38 M | -6.03 | 28 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $6.14 | $116.38 M | -4.5 | 13 | $0 |
 PASG
|
Passage Bio, Inc. | $0.68 | $73.04 M | -0.77 | 58 | $0 |
 REPL
|
Replimune Group, Inc. | $11.16 | $485.18 M | -2.44 | 331 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $44.15 | $6.66 B | -10.51 | 443 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $12.23 | $774.50 M | -6.14 | 110 | $8.78 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |